FIELD: chemistry.
SUBSTANCE: claimed invention relates to method of obtaining pegylated oligonucleotide, which can be used for obtaining biologically active substances. Method includes: (a) synthesis of non-pegylated oligonucleotide on solid carrier, (b) cleavage of non-pegylated oligonucleotide from solid carrier and removal of protective groups from oligonucleotide, (c) desalination of non-pegylated oligonucleotide with application of ultrafiltration, (d) pegylation of non-pegylated oligonucleotide to obtain pegylated oligonucleotide, (e) purification of pegylated oligonucleotide with application of anion-exchange HPLC, (f) desalination and additional purification of pegylated oligonucleotide with application of ultrafiltering membrane with threshold of molecular weight from 10 kDa to 30 kDa, where ion-exchange purification of non-pegylated oligonucleotide is not realised between stages (b) and (c).
EFFECT: claimed method is characterised by improved efficiency.
10 cl, 10 dwg, 11 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR POLYALKOXYLATING NUCLEIC ACIDS, ALLOWING FOR EXTRACTION AND REUSE OF EXCESS POLYALKOXYLATING REAGENT | 2017 |
|
RU2765027C2 |
PEG-CONTAINING CONJUGATES OF HGF-NK4 | 2002 |
|
RU2293574C2 |
ANTICOAGULANT WITH DIRECT ACTION BASED ON MODULAR BIVALENT DNA OF APTAMER SELECTIVE TO THROMBIN | 2016 |
|
RU2631829C1 |
DOSAGE FORM OF DNA-APTAMER | 2019 |
|
RU2730000C1 |
COMPLEMENT-BINDING APTAMERS AND C5 AGENTS APPLICABLE FOR TREATING OCULAR DISORDERS | 2007 |
|
RU2477137C2 |
PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING GROWTH HORMONE-ASSOCIATED DISEASES IN HUMANS | 2014 |
|
RU2689336C2 |
GLYCOPOLYSIALYLATION OF PROTEINS THAT ARE NOT THE PROTEINS OF THE BLOOD CLOTTING | 2014 |
|
RU2662807C2 |
GLYCOPOLYSIALYLATION OF PROTEINS, WHICH ARE NOT BLOOD CLOTTING PROTEINS | 2010 |
|
RU2533619C2 |
NEW METHOD FOR OBTAINING LONG-ACTING DRUG CONJUGATE BY PRODUCING INTERMEDIATE | 2019 |
|
RU2805873C2 |
PHARMACEUTICAL COMPOSITION AND A METHOD OF TREATMENT OF GROWTH HORMONE-RELATED DISEASES IN HUMANS | 2019 |
|
RU2802215C2 |
Authors
Dates
2015-10-10—Published
2012-04-26—Filed